Eisai Corporation of North America, Inc., a subsidiary of the global pharmaceutical company Eisai Co., Ltd., is headquartered in the United States. Established in 1995, the company has made significant strides in the biopharmaceutical industry, focusing on neurology and oncology. With major operational regions across North America, Eisai is dedicated to developing innovative treatments that address unmet medical needs. Eisai's core products include a range of prescription medications, particularly in the fields of Alzheimer's disease and cancer care, distinguished by their commitment to patient-centric solutions. The company has achieved notable recognition for its contributions to healthcare, positioning itself as a leader in the pharmaceutical market. Through continuous research and development, Eisai remains at the forefront of advancing therapeutic options that enhance the quality of life for patients worldwide.
We don't have data for Eisai Corporation of North America, Inc., but we can show you information about their parent organization instead.
View parent company